Trailing-twelve-month (TTM) revenue is $36.97 Million with a year-over-year growth of (77.73%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $9,866,115 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-09-30 |
| Q4 FY2025Period ended 2025-12-31 | $19,732,229 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-24 |
| Q1 FY2026Period ended 2026-03-31 | $3,687,916 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-31 |
| Q2 FY2026Period ended 2026-06-30 | $3,687,916 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-09-25 |
| TTM revenue | $36,974,176 |
Current P/S: $242,210,844 market capitalization ÷ $36,974,176 TTM revenue = 6.55x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T15:10:16.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $3.69M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T15:11:02.921Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T15:11:02.921Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20252025-12-31 · USD |
|---|---|
| HONG KONG | $13M |
| Non-US | $628,482 |
| UNITED STATES | $1M |
$36.97M
$36.97 Million
(77.73%)
vs. $166.03M a year ago (TTM)
(48.79%)
3 Year compound annual growth rate
1 Year
(77.73%)
3 Year
(48.79%)
5 Year
N/A
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $67.40M | ($234.88M) | (77.70%) |
| 2024 | $302.28M | +$45.01M | +17.50% |
| 2023 | $257.27M | +$242.21M | +1609.02% |
| 2022 | $15.05M | ($6.47M) | (30.05%) |
TTM Growth
(77.73%)
3-Year CAGR
(48.79%)
5-Year CAGR
N/A
